Table 3 Clinical trial participationNumber (%) of patients who agree/strongly agree to survey questions grouped by demographic characteristics of interest
From: Understanding the attitudes of the elderly towards enrolment into cancer clinical trials
| Â | Age | Health Status | Cancer Status | |||
|---|---|---|---|---|---|---|
Question | n/N (%) < 75 n/N (%) ≥ 75 | p-value | n/N (%) Good/Excellent n/N (%) Poor/Marginal/Ave | p-value | n/N (%) Cured n/N (%) Not Cured | p-value |
1) I would participate in 'clinical trials' that study ways to prevent or screen for cancer | 34/44 (77) 35/46 (76) | Â | 36/47 (77) 30/40 (75) | Â | 18/29 (62) 42/48 (88) | Â |
| Â | Â | 0.89 | Â | 0.86 | Â | 0.009 |
2) I would participate in a 'clinical trial' to compare a new drug to the old "standard" drug | 24/43 (56) 21/46 (46) | Â | 24/47 (51) 20/39 (51) | Â | 13/30 (43) 25/47 (53) | Â |
| Â | Â | 0.34 | Â | 0.98 | Â | 0.40 |
3) I would participate in a clinical trial to test a new drug when there is no "standard" drug available | 34/45 (76) 30/47 (64) | Â | 32/47 (68) 29/42 (69) | Â | 18/30 (60) 37/49 (76) | Â |
| Â | Â | 0.22 | Â | 0.92 | Â | 0.15 |